Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14

To evaluate the relationship of genetic variability of adiponectin (ADIPOQ), leptin (LEP) and leptin receptor (LEPR) genes with glucose‐insulin system and markers of subclinical atherosclerosis (ATS) in patients with newly diagnosed type 2 diabetes.

[1]  C. Calhau,et al.  Decreased adiponectin/leptin ratio relates to insulin resistance in adults with obesity. , 2022, American journal of physiology. Endocrinology and metabolism.

[2]  M. Yandell,et al.  A dominant negative ADIPOQ mutation in a diabetic family with renal disease, hypoadiponectinemia, and hyperceramidemia , 2022, NPJ genomic medicine.

[3]  M. Jo,et al.  The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome , 2022, Molecules.

[4]  F. Akter,et al.  Adiponectin gene polymorphisms associated with diabetes mellitus: A descriptive review , 2021, Heliyon.

[5]  E. Trabetti,et al.  Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) , 2021, Journal of Endocrinological Investigation.

[6]  Vernicia Hernandez,et al.  The New Kid on the Block: The Mechanisms of Action of Hyperleptinemia in Coronary Artery Disease and Atherosclerosis , 2021, Cureus.

[7]  P. Raman,et al.  Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells , 2021, International journal of molecular sciences.

[8]  U. Adiga,et al.  Association of insulin resistance and leptin receptor gene polymorphism in type 2 diabetes mellitus , 2021, Journal of the Chinese Medical Association : JCMA.

[9]  K. Sayehmiri,et al.  Association between plasma leptin/adiponectin ratios with the extent and severity of coronary artery disease , 2020, BMC Cardiovascular Disorders.

[10]  Xin Wang,et al.  Meta-analysis of the association between adiponectin SNP 45, SNP 276, and type 2 diabetes mellitus , 2020, PloS one.

[11]  E. Bonora,et al.  Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 , 2020, BMJ open diabetes research & care.

[12]  J. Després,et al.  Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. , 2020, Circulation research.

[13]  J. Elmquist,et al.  Leptin: Less Is More , 2020, Diabetes.

[14]  A. Khaire,et al.  Leptin as a predictive marker for metabolic syndrome. , 2019, Cytokine.

[15]  O. Barbarash,et al.  Leptin resistance: underlying mechanisms and diagnosis , 2019, Diabetes, metabolic syndrome and obesity : targets and therapy.

[16]  E. Trabetti,et al.  A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes. , 2018, Diabetes research and clinical practice.

[17]  J. Kanu,et al.  Associations between three common single nucleotide polymorphisms (rs266729, rs2241766, and rs1501299) of ADIPOQ and cardiovascular disease: a meta-analysis , 2018, Lipids in Health and Disease.

[18]  T. Niu,et al.  A meta-analysis of associations of LEPR Q223R and K109R polymorphisms with Type 2 diabetes risk , 2018, PloS one.

[19]  R. Leis,et al.  Leptin Receptor Gene Variant rs11804091 Is Associated with BMI and Insulin Resistance in Spanish Female Obese Children: A Case-Control Study , 2017, International journal of molecular sciences.

[20]  Li Jin,et al.  Association of maternal and fetal LEPR common variants with maternal glycemic traits during pregnancy , 2017, Scientific Reports.

[21]  S. Jain,et al.  Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction , 2017, International journal of molecular sciences.

[22]  Q. Ma,et al.  Associations between two common single nucleotide polymorphisms (rs2241766 and rs1501299) of ADIPOQ gene and coronary artery disease in type 2 diabetic patients: a systematic review and meta-analysis , 2017, Oncotarget.

[23]  Q. Ma,et al.  Associations between two common single nucleotide polymorphisms (rs2241766 and rs1501299) of ADIPOQ gene and coronary artery disease in type 2 diabetic patients: a systematic review and meta-analysis , 2017, Oncotarget.

[24]  M. Ruscica,et al.  Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[25]  T. Ng,et al.  Variations in the Obesity Gene “LEPR” Contribute to Risk of Type 2 Diabetes Mellitus: Evidence from a Meta-Analysis , 2016, Journal of diabetes research.

[26]  B. M. Abdullah,et al.  Genetic polymorphisms associated with overweight and obesity in uncontrolled Type 2 diabetes mellitus. , 2016, Biomarkers in medicine.

[27]  J. Young,et al.  Relation between ADIPOQ Gene Polymorphisms and Type 2 Diabetes , 2015, Genes.

[28]  P. Mirmiran,et al.  The Association of Polymorphisms in Leptin/Leptin Receptor Genes and Ghrelin/Ghrelin Receptor Genes With Overweight/Obesity and the Related Metabolic Disturbances: A Review , 2015, International journal of endocrinology and metabolism.

[29]  S. Kihara,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. , 2012, Biochemical and biophysical research communications.

[30]  C. Mantzoros,et al.  Effects of leptin and adiponectin on pancreatic β-cell function. , 2011, Metabolism: clinical and experimental.

[31]  A. Xu,et al.  Hypoadiponectinemia predicts impaired endothelium-independent vasodilation in newly diagnosed type 2 diabetic patients: an 8-year prospective study. , 2011, Chinese medical journal.

[32]  Constantin Ionescu-Tirgoviste,et al.  Relationship between plasma adipokines, inflammation, insulin resistance and subclinical atherosclerosis in newly diagnosed type 2 diabetes , 2011 .

[33]  E. Trabetti,et al.  Variants of GCKR Affect Both β-Cell and Kidney Function in Patients With Newly Diagnosed Type 2 Diabetes , 2011, Diabetes Care.

[34]  S. Akira,et al.  Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. , 2011, Cell metabolism.

[35]  E. Trabetti,et al.  Variants and haplotypes of TCF7L2 are associated with β-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1. , 2011, The Journal of clinical endocrinology and metabolism.

[36]  T. Heise,et al.  Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. , 2010, The Journal of clinical endocrinology and metabolism.

[37]  G. Steinberg,et al.  Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.

[38]  A. Doria,et al.  Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family‐based study , 2010, Journal of internal medicine.

[39]  F. Visseren,et al.  Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. , 2008, European heart journal.

[40]  P. Cabello,et al.  LEPR p.Q223R, beta3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects. , 2007, Genetics and molecular research : GMR.

[41]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[42]  C. Meisinger,et al.  Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. , 2006, Journal of the American College of Cardiology.

[43]  Kazuo Kimura,et al.  Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. , 2006, Journal of the American College of Cardiology.

[44]  N. Hou,et al.  Leptin and cardiovascular diseases , 2011, Clinical and experimental pharmacology & physiology.

[45]  A. Doria,et al.  The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. , 2004, Diabetes care.

[46]  E. Rimm,et al.  Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. , 2004, Diabetes care.

[47]  S. Kihara,et al.  Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages , 2004, Circulation.

[48]  M. Matsuda,et al.  Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.

[49]  P. Scherer,et al.  A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. , 2002, Diabetes.

[50]  C. Dina,et al.  Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. , 2002, Diabetes.

[51]  C. Bouchard,et al.  Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance. , 2001, The Journal of clinical endocrinology and metabolism.

[52]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[53]  S. Kiechl,et al.  Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[54]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[55]  H. Randeva,et al.  Role of adipokines in cardiovascular disease. , 2013, The Journal of endocrinology.

[56]  E. Trabetti,et al.  Variants of GCKR Affect Both b -Cell and Kidney Function in Patients With Newly Diagnosed Type 2 Diabetes The Verona Newly Diagnosed Type 2 Diabetes Study 2 , 2011 .

[57]  M. Górska,et al.  Plasma adiponectin and E-selectin concentrations in patients with coronary heart disease and newly diagnosed disturbances of glucose metabolism. , 2006, Advances in medical sciences.

[58]  P. Scherer.  From Lipid Storage Compartment to Endocrine Organ , 2006 .

[59]  Mark I. McCarthy,et al.  Mendelian Randomization Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes , 2013, Diabetes.